PsychoGenics, a private biopharmaceutical company, with expertise in the field of behavioral neurobiology, and provider CNS drug discovery solutions to Pharmaceutical and Biotechnology companies, is combining its expertise in behavior with the power of bioinformatics to develop a breakthrough, in vivo preclinical behavioral testing platform. This automated and computerized high-throughput platform offers companies an alternative approach to target discovery and validation, and drug discovery by providing faster, more objective and higher quality results than traditional, subjective manual approaches.